After being approved by the US Food and Drug Administration (FDA), there is a good chance that Biogen's Alzheimer's drug will also be approved in Europe, Sydbank Senior Analyst Søren Løntoft Hansen says.
The FDA has approved Biogen's Alzeheimer's treatment Aduhelm for use in the US, but it has not been approved in Europe, though there is a good chance this will happen, says Løntoft Hansen.
Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
More from MedWatch
Orphazyme cuts guidance following FDA setback
Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.
US OTC hearing aid channel back on Department of Health agenda
The US health department aims to have a hearing on publishing the regulatory framework for selling hearing aids over the course of the year.
More disappointment for Orphazyme as FDA rejects Niemann Pick C application
The FDA have rejected an application for marketing authorization for Orphazyme's main drug candidate, arimoclomol, as a treatment for metabolic disease Niemann Pick C. The authority wants more data.
Orphazyme CEO silent on potential firings in wake of FDA rejection
The FDA rejection of Orphazyme's drug candidate in its main indication will trigger major cuts at the biotech firm, but CEO Christophe Bourdon has no comment on where they will be implemented and how hard the US organization will be hit.
Top Orphazyme figure on FDA rejection: "It is very disappointing and very unexpected"
Biotech heavyweight Bo Jesper Hansen is very disappointed over the FDA rejection of Orphazyme's only drug candidate.
Radiochemist in CMC Development - Y-mAbs Therapeutics 
Principal Biostatistician - ALK 
Regulatory affairs life cycle specialist 
Senior Clinical Development Scientist/Physician - Lundbeck 
Principal Formulation Scientist, Oral Formulation Research - Novo Nordisk 
Clinical Business Process Manager - Genmab 
eTMF Manager - Klifo 
(Senior) Regulatory Science Specialist - IWA Consulting 
Analytical Coordinator (Senior scientist) – Permanent position, Symphogen